retatrutide trial results news Weight Loss Results:Trial Data and FDA Status Triple hormone receptor agonist retatrutide
Description
GLP-1 medications are glucagon-like peptide-1 (GLP-1) receptor agonists approved for treating Type 2 diabetes and, more recently, for chronic weight management
After a year of evaluating this space with our clinical partners, we believe we can deliver equal if not better experiences for the millions of people who deserve to find success with a solution that has been personalized for their needs
Key References Flint A, Raben A, Astrup A, Holst JJ
When your appetite window opens, you dont want to be evaluating ingredient lists
